Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other Psychoactive Substance Dependence with Psychoactive Substance-Induced Mood Disorder
- ICD-10 Code: F19.24
Summary
This condition involves a pattern of dependence on non-classified psychoactive substances (excluding alcohol, opioids, or cannabis) that is complicated by a mood disorder directly induced by the substance use. The dependence is marked by a strong desire to use the substance, difficulty controlling use, and continued use despite negative consequences, while the mood disorder (e.g., depression or mania) is attributed to the substance's effects on brain function.
Causes
The causes include chronic use of psychoactive substances that alter neurotransmitter activity, leading to both dependence and mood dysregulation. Psychological factors like stress or trauma may exacerbate substance use, and the substance's pharmacological effects can directly induce mood symptoms. Social or environmental influences, such as access to substances or peer pressure, may also contribute to the development of dependence and subsequent mood disturbances.
Risk Factors
- Genetic predisposition to addiction or mood disorders
- Co-occurring mental health conditions (e.g., anxiety, depression)
- Early exposure to psychoactive substances
- Environmental factors (e.g., substance availability, social norms)
Symptoms
- Intense cravings or urges to use the substance
- Inability to reduce or control substance use despite efforts
- Withdrawal symptoms (e.g., irritability, fatigue) when not using
- Mood disturbances (e.g., persistent sadness, elevated mood) directly linked to substance use
- Neglect of personal, occupational, or social responsibilities
Diagnosis
Diagnosis requires a thorough medical and psychological evaluation, including patient self-reports of substance use patterns and mood symptoms. Clinicians assess whether the mood disorder is substance-induced by evaluating the temporal relationship between substance use and mood changes, ruling out other causes (e.g., primary mood disorders). Standardized questionnaires or diagnostic criteria (e.g., DSM-5) may be used to confirm dependence and mood disorder severity.
Treatment Options
Treatment typically involves a combination of pharmacotherapy to manage withdrawal or mood symptoms, psychotherapy (e.g., cognitive-behavioral therapy) to address dependence and coping skills, and support groups. Addressing the underlying mood disorder is critical, with medications tailored to the specific symptoms (e.g., antidepressants for depression). Long-term follow-up and relapse prevention strategies are often necessary.
Prognosis and Follow-Up
Prognosis depends on the severity of dependence and mood disorder, as well as adherence to treatment. With consistent care, many individuals achieve stability, but relapse risk remains. Regular follow-up appointments monitor substance use, mood symptoms, and treatment response, allowing for adjustments to the care plan as needed.
Complications
Complications may include worsening mood symptoms (e.g., suicidal ideation), physical health issues from substance use (e.g., organ damage), social or occupational impairment, and increased risk of other substance-related disorders. Untreated, the condition can lead to chronic disability or life-threatening situations.
Lifestyle & Prevention
Lifestyle modifications include avoiding triggers for substance use, engaging in healthy coping mechanisms (e.g., exercise, mindfulness), and building a support network. Prevention focuses on education about the risks of non-classified psychoactive substances and early intervention for at-risk individuals.
When to Seek Professional Help
Seek help if substance use is uncontrollable, mood symptoms interfere with daily life, or withdrawal symptoms occur. Immediate care is needed for severe mood disturbances (e.g., suicidal thoughts) or signs of overdose.
Tips for Medical Coders
Document the presence of both substance dependence and a substance-induced mood disorder, including the temporal link between substance use and mood symptoms. Ensure clinical notes specify the substance type (if known) and confirm the mood disorder is directly attributable to the substance, not a primary condition. Code F19.24 is appropriate when both dependence and a substance-induced mood disorder are present.
F19.24 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.